Innoplexus is a consulting product development firm for Life science organisations offering Data as a Service (DaaS) and Continuous Analytics as a Service (CAaS) products, leveraging Artificial Intelligence and advanced analytics to help reduce the drug development time, from synthesis to approval, significantly.
Our products leverage proprietary algorithms and patent pending technologies to help global Life Sciences and Pharmaceuticals organisations across all, pre-clinical, clinical, regulatory and commercial stages of a drug. Thus achieving a significant and overall reduction in the drug development time.
We ensure the best ROI by automating the collection, curation, aggregation and analysis, of billions of data points from thousands of data sources, using machine learning, network analysis, ontologies, computer vision and entity normalisation.
Check “iPlexus – The Intelligence Machine” a platform to expedite drug development process!!